Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450-dependent steroidogenic enzymes are a family of heme-containing monooxygenases that catalyze key steps in the biosynthesis of steroid hormones from cholesterol. These enzymes, including CYP11A1, CYP11B1, CYP11B2, CYP17A1, CYP19A1, and CYP21A2, are essential for the production of glucocorticoids, mineralocorticoids, and sex steroids. Their activity is tightly regulated and alterations can lead to various endocrine disorders. CYP17A1, in particular, has dual 17α-hydroxylase and 17,20-lyase activities, making it a crucial branch point in steroidogenesis. Inhibition of these enzymes is a therapeutic strategy for conditions like prostate cancer.
Inhibition of steroid hormone synthesis by blocking specific CYP enzyme activity.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450-Dependent Steroidogenic Enzymes (Steroidogenic CYPs).